论文标题： Circular RNA CDR1as Exerts Oncogenic Properties Partially through Regulating MicroRNA 641 in Cholangiocarcinoma
DOI： 10.1128/MCB.00042-20
发表时间： 2020-07-14
期刊： MOLECULAR AND CELLULAR BIOLOGY
影响因子： 3.611
货号： ZQ0247
产品名称： RBE cells
原文链接： https://mcb.asm.org/content/early/2020/05/14/MCB.00042-20.abstract

论文标题： Forced overexpression of FBP1 inhibits proliferation and metastasis in cholangiocarcinoma cells via Wnt/β-catenin pathway
DOI： 10.1016/j.lfs.2018.09.009
发表时间： 2018-09-04
期刊： LIFE SCIENCES
影响因子： 3.234
货号： ZQ0247
产品名称： RBE cells
原文链接： https://www.sciencedirect.com/science/article/pii/S0024320518305551

论文标题： Thymidine phosphorylase promotes angiogenesis and tumour growth in intrahepatic cholangiocarcinoma
DOI： 10.1002/cbf.3541
发表时间： 2020-05-31
期刊： CELL BIOCHEMISTRY AND FUNCTION
影响因子： 2.632
货号： ZQ0247
产品名称： Human cholangiocarcinoma RBE cells
原文链接： https://onlinelibrary.wiley.com/doi/abs/10.1002/cbf.3541

论文标题： Anti-influenza A (H1N1) viral and cytotoxic sesquiterpenes from Carpesium abrotanoides
DOI： 10.1016/j.phytol.2019.10.013
发表时间： 2019-11-15
期刊： Phytochemistry Letters
影响因子： 1.338
货号： ZQ0247
产品名称： RBE cells

原文链接： https://www.sciencedirect.com/science/article/pii/S187439001930518X

PubMed=9358283; DOI=10.1007/s11626-997-0125-z
Enjoji M., Sakai H., Nawata H., Kajiyama K., Tsuneyoshi M.
Sarcomatous and adenocarcinoma cell lines from the same nodule of cholangiocarcinoma.
In Vitro Cell. Dev. Biol. Anim. 33:681-683(1997)

PubMed=15767549; DOI=10.1158/1535-7163.MCT-04-0234
Nakatsu N., Yoshida Y., Yamazaki K., Nakamura T., Dan S., Fukui Y., Yamori T.
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
Mol. Cancer Ther. 4:399-412(2005)

CLPUB00275

PubMed=27231123; DOI=10.1158/2159-8290.CD-15-1442
Saha S.K., Gordan J.D., Kleinstiver B.P., Vu P., Najem M.S., Yeo J.-C., Shi L., Kato Y., Levin R.S., Webber J.T., Damon L.J., Egan R.K., Greninger P., McDermott U., Garnett M.J., Jenkins R.L., Rieger-Christ K.M., Sullivan T.B., Hezel A.F., Liss A.S., Mizukami Y., Goyal L., Ferrone C.R., Zhu A.X., Joung J.K., Shokat K.M., Benes C.H., El-Bardeesy N.
Isocitrate dehydrogenase mutations confer dasatinib hypersensitivity and SRC dependence in intrahepatic cholangiocarcinoma.
Cancer Discov. 6:727-739(2016)

PubMed=31077409; DOI=10.1002/hep.30704
Sittithumcharee G., Suppramote O., Vaeteewoottacharn K., Sirisuksakun C., Jamnongsong S., Laphanuwat P., Suntiparpluacha M., Matha A., Chusorn P., Buraphat P., Kakanaporn C., Charngkaew K., Silsirivanit A., Korphaisarn K., Limsrichamrern S., Tripatara P., Pairojkul C., Wongkham S., Sampattavanich S., Okada S., Jirawatnotai S.
Dependency of cholangiocarcinoma on cyclin D-dependent kinase activity.
Hepatology 70:1614-1630(2019)

PubMed=35640676; DOI=10.1016/j.ajpath.2022.05.007
Isidan A., Yenigun A., Soma D., Aksu E., Lopez K., Park Y., Cross-Najafi A., Li P., Kundu D., House M.G., Chakraborty S., Glaser S., Kennedy L., Francis H., Zhang W.-J., Alpini G.D., Ekser B.
Development and characterization of human primary cholangiocarcinoma cell lines.
Am. J. Pathol. 192:1200-1217(2022)